High-Dose Hemodialysis versus Conventional In-Center Hemodialysis: A Cost-Utility Analysis from a UK Payer Perspective

Although high-dose HD has the potential to offer improved clinical and quality-of-life outcomes over conventional ICHD, under the current UK Payment-by Results reimbursement scheme, it would be considered cost-effective from a UK payer perspective only if conducted at home.